ALUNBRIG-Brigatinib Tablets

Detailed inquiry page for ALUNBRIG-Brigatinib Tablets with product identification and document review notes.

Products / Oncology & Hematology

Product Detail

ALUNBRIG-Brigatinib Tablets

Detailed inquiry page for product identification, sourcing review, document preparation, and shipment planning.

Inquiry review onlyNo online sale impliedDocument check required

Product Review Summary

1

CategoryOncology & Hematology

2

Inquiry TypePrescription medicine sourcing review

3

AvailabilityConfirmed after destination and document review

Product Information

Identification details

Product Name ALUNBRIG-Brigatinib Tablets
Therapeutic / Supply Category Oncology & Hematology
Trade Name ALUNBRIG
Generic Name Brigatinib Tablets
Strength / Pack Size 180mg*28Tablets/box/pack
Manufacturer Penn Pharmaceutical Services Ltd(UK),; Takeda Ireland Limited(Ireland)
MA Holder Takeda Pharma A/S(Denmark)
Approval / Registration HJ20220021

Inquiry Requirements

What MEDIHALL needs to review this product

Product matchConfirm brand/generic name, dosage form, strength, package size, and target quantity.
Destination and purposeShare destination country, consignee type, project purpose, and target timeline.
Document checklistTell us whether invoice, packing list, certificate, registration, customs, or buyer-specific documents are needed.
Handling conditionsConfirm cold-chain, shelf-life, storage, urgency, and shipment handover requirements.
Availability reviewMEDIHALL reviews supply feasibility after product and destination details are clear.
Compliance noteProduct listing does not guarantee availability and does not imply direct online sale.

Inquiry

Ask MEDIHALL to review ALUNBRIG-Brigatinib Tablets

Send product details, destination country, quantity, timeline, and document requirements for review.

Email:

Phone: